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Background and objective: The study was performed to determine whether catch-up growth is associated with
the development of insulin resistance and to explore serum endocrine markers associated with the metabolism of
adipose tissue in a Chinese population born small for gestational age(SGA)
Subjects and methods: We recruited 56 children born SGA with catch-up growth and 55 born without catch-up
growth, who were further grouped into groups I (with BMI catch-up) and II (without BMI catch-up) respectively, as
well as 52 children born appropriate for gestational age (AGA) with normal height. Their serum fasting insulin,
fasting glucose, insulin-like growth factor-1, adiponectin, IGFBP-1, triglyceride concentrations, and the homeostasis
assessment model for insulin resistance (HOMA-IR) were evaluated.
Results: (1) The HOMA-IR values in SGA-I with catch-up growth group were significantly higher than those in
SGA-II with catch-up growth, SGA-I without catch-up growth and AGA children respectively. (2) The serum
adiponectin levels of individuals in the SGA-I without catch-up growth and SGA-II with catch-up growth groups
were significantly lower than those from the SGA-II without catch-up growth group. There was no difference in
triglyceride or IGFBP-1 levels among the groups. (3) The degree of HOMA-IR was positively correlated with age,
current BMI and △height SDS in SGA children.
Conclusion: The development of insulin resistance and lower levels of adiponectin were closely correlated with
higher BMI and the postnatal height catch-up growth in SGA children.
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Epidemiological studies have suggested that children born
small for gestational age (SGA) are at higher risk for devel-
oping metabolic syndromes in adulthood, including insu-
lin resistance, type 2 diabetes, and cardiovascular diseases
[1-3]. The “thrifty phenotype” hypothesis suggests that
early life metabolic adaptations aid in the survival of an or-
ganism by selecting an appropriate growth trajectory in re-
sponse to adverse intrauterine environmental cues [2].* Correspondence: dhz1114@yahoo.cn
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reproduction in any medium, provided the orCatch-up growth in postnatal development is very com-
mon in young children born SGA. Previous studies have
shown that children born SGA with catch-up growth ex-
hibit fat accumulation, abnormal development of adipose
tissue and adipocyte function caused by adverse intrauter-
ine growth, which contributes to the development of insu-
lin resistance [4-7]. However, most of these previous
studies did not discuss the contribution of height and fat
catch-up growth to insulin resistance, though the strong
association between low birth weight and insulin resist-
ance has been described [8-10]. Hence, the discovery of
the relative contribution of catch-up growth to the devel-
opment of insulin resistance is of great importance for
developing strategies to prevent insulin resistance-relatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion. Adiponectin, IGFBP-1and triglycerides have been
implicated in the pathophysiology of obesity-related insu-
lin resistance, glucose intolerance, and insulin-mediated
lipoprotein metabolism. Hypoadiponectinemia has been
associated with insulin resistance in both animal and
human studies. Only limited and controversial informa-
tion is available about circulating adiponectin, IGFBP-
1and triglyceride levels in pre-pubertal children born SGA
[11-13].
This study is a retrospective study aiming to determine
whether children born SGA with catch-up growth are
associated with the early development of insulin resist-
ance in a Chinese population and investigating adipo-
nectin, IGFBP-1and triglyceride levels in SGA children,
while accounting for the height and fat catch-up growth.Subjects and methods
A total of 111 children born SGA and 52 children born
AGA were recruited from out-patient services at the
Department of Pediatrics and Obstetrics of the First
Affiliated Hospital, Sun Yat-Sen University for regular
physical examination from Jan 2006 to Dec 2009. The
SGA children were all follow-up cases born in our
hospital, and they received regular physical examination
once every one to three months. The maternal age of
SGA groups was (30 ± 4) years. Multiple gestation
(30/111, 27%), gestational hypertension/pre-eclampsia
(21/111, 19%), pre-existing (before pregnancy) diabetes
(12/111,11%), gestational diabetes (10/111, 9%), intrahe-
patic cholestasis of pregnancy(8/111, 7%), maternal in-
fection with syphilis or HIV(3/111, 3%), maternal smo-
king or alcohol use or illicit drug use during pregnancy
(2/111, 2%) were included in SGA groups.
All of the children with age range 3.5yr to 10.2yr were
born between 37 and 42 weeks of gestation, were non-
obese (based on the standard deviation score (SDS) of
body mass index ≤2 for the chronological age and
gender) and were in the pre-pubertal period defined
as Tanner I. SGA was defined as a birth weight and
length < −2 standard deviation (SD), and AGA was
defined as individuals with a birth weight and length ≥−2
SD and ≤ 2 SD for the gestational age, according to
Chinese standards [9]. The SGA children were furtherTable 1 Grouping criteria for the SGA and AGA groups
①SGA-I with catch-up growth (n=40; 23F, 17M) Birth lengt
②SGA-II with catch-up growth (n=16; 7F, 9M) Birth lengt
③SGA-I without catch-up growth (n=37; 16F, 21M) Birth lengt
④SGA-II without catch-up growth (n=18; 8F, 10M) Birth lengt
⑤AGA(n=52; 23F, 29M) Birth lengt
AGA: Appropriate for gestational age; SGA: Small for gestational age; BMI: Body ma
△Height SDS: Current height SDS corrected minus birth length SDS; △BMI SDS: Currdivided into four groups (Table 1): SGA-I with catch-
up growth (n=40; 23F, 17M), SGA-II with catch-up
growth (n=16; 7F, 9M), SGA-I without catch-up
growth (n=37; 16F, 21M),and SGA-II without catch-
up growth (n=18; 8F, 10M). Children born SGA without
catch-up growth had serum maximum growth hormone
(GH) levels of greater than 10 μg/L(results from GH-
provocative tests using Levodopa and Pyridostigmine).
GH therapy was not administered to all of the SGA Chil-
dren during the follow-up period. The AGA group of
children (n=52; 23F, 29M) with normal height and weight
were matched according to age, gender and Tanner stage
in the SGA groups.
Individual subjects who had chromosome abnormalities,
congenital skeletal deformations, hypothyroidism, congeni-
tal malformation-related growth retardation, chronic dis-
eases, or long-term medication were excluded. Children,
with first-degree relatives who suffered from type 2 diabetes
and metabolic syndrome, or who were born from mothers
with gestational diabetes, were excluded. Obese children
were also excluded to avoid another confounding factor in
our study.
Informed consent was obtained from their parents,
and the experimental 1 protocol was approved by the
Local Ethics Committee.Measurements
An individual’s birth length and weight were obtained
from hospital records and their target heights were calcu-
lated as mid-parental height minus 6.5 cm for girls and
mid-parental height plus 6.5 cm for boys. Their current
height, weight, and body mass index (BMI) were also mea-
sured. Age- and gender-adjusted SDS for height, weight,
and BMI were calculated using reference tables of Chinese
children [14,15]. The SDScorrected height for individual
subjects was calculated using the actual height SDS minus
target height SDS. The △ height SDS was calculated using
the current height SDScorrected minus birth length SDS,
while the △weight SDS was determined using the current
weight SDS minus birth weight SDS. The BMI of individ-
ual children was calculated as weight (kg)/height (m)2 .
The △BMI SDS was determined using the current BMI
SDS minus birth BMI SDS. The demographic characteris-
tics and measured values are listed in Table 2.h SDS< −2, Height SDSCorrected>−2 and △BMI SDS>0
h SDS< −2, Height SDSCorrected>−2 and △BMI SDS≤0
h SDS< −2, Height SDSCorrected≤−2 and △Height SDS≤0 and △BMI SDS>0
h SDS< −2, Height SDSCorrected≤−2 and △Height SDS≤0 and △BMI SDS≤0
h SDS≥ −2 and ≤2, Height SDSCorrected>−2
ss index; Height SDSCorrected: Actual height SDS minus target height SDS;
ent BMI SDS minus birth BMI SDS.










n=40 n=16 n=37 n=18 n=52
Gender(M:F) 17:23 9:7 21:16 10:8 29:23
Midparental height
(cm)
161.38±0.80 162.27±0.45 162.75±0.54 162.00±0.73 160.14±0.44
Age(year) 6.78±0.88 6.27±0.96 5.30±0.67 5.91±0.98 7.14±0.39
Gestational age
(weeks)
38.76±0.21 39.17±0.19 38.76±0.21 39.17±0.19 39.23±0.14
Birth weight SDS −2.27±0.18* −1.82±0.39* −2.61±0.11* −1.83±0.25* 0.23±0.04
Birth length SDS −2.42±0.14* −3.00±0.25* −2.02±0.21* −2.29±0.19* 0.14±0.03
Birth BMI SDS −1.51±0.37* −1.29±0.45* −1.91±0.45* −1.47±0.38* 0.39±0.24
Weight SDS −1.65±0.41 −2.18±0.53 −2.11±0.37 −4.02±0.57* −1.41±0.25
Height SDSCorrected −0.93±0.22 −1.49±0.15 −3.24±0.18
* −2.82±0.29* −1.05±0.07
BMI SDS −0.15±0.19 # −1.18±0.19 −0.76±0.25 # −1.63±0.25* −0.32±0.12
△Height SDS 1.57±0.27* 1.51±0.21* −1.24±0.26 −1.21±0.23 −0.73±0.28
△Weight SDS 0.63±0.39* # −0.36±0.34 0.50±0.35* # −2.19±0.46 −1.52±0.37
△BMI SDS 1.36±0.47* # −0.06±0.35 1.33±0.36* # −0.17±0.34 −0.71±0.25
*P<0.05 SGA-I or SGA-II vs AGA; #P<0.05 SGA-I vs SGA-II.
AGA: Appropriate for gestational age; SGA: Small for gestational age; BMI: Body mass index; △Height SDS: Current height SDS corrected minus birth length SDS;
△Weight SDS: Current Weight SDS minus birth Weight SDS; △BMI SDS: Current BMI SDS minus birth BMI SDS.
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After overnight fasting, blood samples were collected and
sera were prepared by centrifugation and stored at −70°C.
The serum glucose concentrations were analysed immedi-
ately. The concentration of serum insulin and IGF-I for in-
dividual subjects were simultaneously determined via
routine laboratory examinations. The concentration of
blood glucose was determined using the hyperoxidase
method (Photometric Instrument 4010; Roche, Basel,
Switzerland). The intra-assay coefficient of variation of
this method was <2.0%. The serum insulin concentrations
were determined via radioimmunoassay (RIA) using the
insulin RIA kit, according to the manufacturer’s instruc-
tions (Phadeseph Insulin RIA, Pharmacia &Upjohn
Diagnostics AB, Uppsala, Sweden). The intra- and inter-
assay coefficients of variation were 5.3% and 7.6%, respect-
ively. The serum IGF-I concentrations were determined
using an ELISA kit, according to the manufacturer’s
instructions (Diagnostic Systems Laboratories −10-2800,
Inc., Webster, TX, USA). The sensitivity of the assay was
0.01 ng/mL. The inter- and intra-assay coefficients of vari-
ation were 3.3-6.8% and 4.5-8.6%, respectively. The
HOMA-IR was calculated as insulin (microunits per milli-
litre) × glucose (millimoles per litre) /22.5 and was used to
evaluate IR in individual children [16].
Statistical analyses
Data were analysed using the Statistical Package for Social
Sciences (SPSS, version 13.0 SPSS Inc, Chicago, IL, USA).
Data for HOMA-IR were transformed into normal distri-
butions by calculating the natural logarithms and wereexpressed as the geometric mean ± standard error of
mean (SEM). All other values were expressed as the arith-
metic mean ±SEM. Comparisons among the groups were
performed using parametric tests. The differences among
groups were assessed by one-way ANOVA and univariate
analysis using Fisher’s protected least significant difference
test for inter-group comparisons. The differences between
two groups were determined using unpaired t tests. Differ-
ences in gender distribution between groups were assessed
by χ2 -tests. Relationships between variables were analysed
by simple correlation (Pearson’s test) and general linear




There was no difference in gender, age, or gestational
age among these groups. As expected, birth weights and
lengths SDS were significantly lower in SGA children
than in AGA children. The values of height SDScorrected
in SGA children without catch-up growth were lower
than those of SGA with catch-up growth and AGA chil-
dren (P<0.001). Moreover the values of BMI SDS in
SGA-I with and without catch-up growth children were
higher than those of SGA-II with and without catch-up
growth children respectively (P<0.001). Furthermore, the
values of BMI SDS in SGA-II without catch-up growth
children were lower than in AGA children (P=0.001),
but there were no significant difference compared to the
children in the SGA-II with catch-up growth group
(P=0.073). There was no difference in BMI SDS among
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groups (P>0.05, Table 2).
Laboratory profile
There was no significant difference in the concentration of
fasting serum glucose among the groups of children. The
HOMA-IR values in SGA-I children with catch-up growth
were significantly higher than in SGA-II with catch-
up growth, SGA-I without catch-up growth and AGA
children. These differences persisted despite adjusting for
gender, age, and BMI (P=0.022, 0.015, 0.029, respectively).
The HOMA-IR values in two SGA groups without catch-
up growth were all comparable to the values in AGA
children (P>0.05).
The levels of adiponectin in the SGA-II with catch-up
growth and SGA-I without catch-up growth groups were
significantly lower than those in the SGA-II without
catch-up growth group respectively (P=0.008, 0.011, re-
spectively). These differences appeared despite adjusting
for BMI (P=0.038, 0.035, respectively). However, there
was no significant difference when compared to the
AGA group. There was no significant difference in the
IGFBP-1and TG values among those groups even after
adjusting for BMI (P>0.05) (Table 3).
Correlation analysis
Correlation analysis indicated that the HOMA-IR values
were positively correlated with age(r=0.375, P=0.003), △Ht
SDS(r=0.431, P=0.000) and BMI (r=0.417, P=0.001), how-
ever, they were not associated with birth weight (P>0.05).
The HOMA-IR values were negatively correlated with
the adiponectin and IGFBP-1 levels (r=−0.33, P=0.03;
r=−0.43, P<0.01) in the SGA group, but no correlation
was observed with the levels of triglycerides. Adiponec-
tin and IGFBP-1 levels exhibited a negative correlation
with chronological age (r=−0.427, P=0.001; r=−0.289,

















*P<0.05 SGA-I or SGA-II vs AGA; #P<0.05 SGA-I vs SGA-II; ▲P<0.05 SGA-I with catch-
SGA-II without catch-up growth.
AGA: Appropriate for gestational age; SGA: Small for gestational age; HOMA: Home
1; IGFBP-1: Insulin-like growth factor binding protein-1.Discussion
In our study, SGA children, who had made a height catch-
up growth accompanied by a BMI catch-up growth, had
significantly higher values of insulin resistance index com-
pared to AGA children. This finding showed that the de-
velopment of insulin resistance was associated with height
and BMI catch-up growth in SGA children, which
increased with age. These data were not in complete ac-
cordance with several previous reports [9,17,18]. The ma-
jority of previous studies did not analyse the contribution
of BMI catch-up growth to insulin resistance during post-
natal catch-up growth, though the strong association be-
tween low birth weight and insulin resistance has been
described [9,17,19]. In our study population, △BMI SDS
values were higher in SGA children than in AGA children.
Because the high degree of BMI usually reflects the excess
accumulation of fat in the body, our data suggest that
there was body fat accumulation in SGA children, espe-
cially with catch-up growth in height during childhood
and that the excess fat contributes to the development of
insulin resistance in SGA children. SGA children with
higher current BMI were more insulin-resistant than AGA
children, in spite of their similar weight and BMI. The data
also suggested that insulin resistance may precede the de-
velopment of obesity. Other studies have suggested that
low birth weight is a risk factor for the later development
of abdominal or truncal obesity, and SGA children with
catch-up weight gain show a dramatic transition to-
ward central adiposity, which enhances insulin resistance
[20-23]. Accordingly, the measures used to control over-
weight when gaining linear catch-up growth in childhood
seem to be important in the prevention of insulin resist-
ance in SGA children. Our findings indicated that height
catch-up growth was an important influential factor for in-
sulin resistance in SGA children. Our work might contrib-
ute to understanding the involvement of catch-up growth











0.09±0.01 0.15±0.07* #▲ 0.09±0.01
90.18±12.74 123.44±21.15 106.54±11.96
126.56±16.35 ▲ 171.11±31.32 175.53±13.69
up growth vs SGA-I without catch-up growth; SGA-II with catch-up growth vs
ostasis assessment model; IR: Insulin resistance; IGF-1: Insulin-like growth factor-
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height might be of potential importance when considering
GH treatment.
Decreased adiponectin and IGFBP-1 levels and increased
triglyceride levels are considered to reflect impaired insulin
sensitivity and predict insulin resistance. Data on adiponec-
tin, IGFBP-1 and triglyceride levels in SGA children in the
literature have varied [24-27]. Adiponectin is one of the adi-
pokines produced exclusively by adipocytes. Adiponectin
knockout mice develop glucose intolerance, insulin resist-
ance, and hyperlipidemia, especially when fed high-fat diets
[28]. Decreased levels of plasma adiponectin have been
found to be related to obesity, type 2 diabetes, and cardio-
vascular disease. Cianfarani et al. reported that the serum
adiponectin levels were lower in SGA children (aged
8.6±3.5yr) than in short-normal children born AGA [29].
These differences were not observed in the research of
Lopez-Bermejo et al. whose extensive analysis revealed
that the group of overweight SGA children had lower
serum adiponectin concentrations than lean SGA children
[30]. Research on preterm infants had shown that the
change in the serum adiponectin levels closely correlated
to gains in body weight in AGA and SGA children [31].
One important finding of the present study was that adi-
ponectin was not only associated with BMI catch-up, but
also with linear catch-up growth in pre-pubertal SGA
children. Our study also showed that adiponectin was in-
versely associated with insulin resistance markers. The
results highlight that BMI and linear catch-up might be
two independent determinants of hypoadiponectinemia in
SGA children. Previous studies have shown that low birth
weight followed by catch-up in body fat, especially visceral
fat during childhood, even within the normal weight
range, was associated with a higher risk of developing in-
sulin resistance [20,22]. Our study also showed that the
decreased adiponectin levels were associated with postna-
tal body fat accumulation in SGA children and added new
information on this association because it showed the rele-
vant role of fat and height catch-up. To the best of our
knowledge, the relationship between linear catch-up and
adiponectin are novel and may contribute to understand-
ing the involvement of adiponectin in the pathogenesis of
insulin resistance in SGA children.
IGFBP-1, produced in the liver, is suppressed by insu-
lin through binding to insulin-response elements in the
IGFBP-1 gene promoter, which forms a link between
glucose metabolism and IGF axis [32]. Insulin resistance
and impaired glucose tolerance are observed in IGFBP-1
transgenic mice [33]. Reduced serum IGFBP-1 levels are
considered to reflect hyperinsulinemia and cardiovascu-
lar risk in adults and obese children [32,34]. Kamoda T
et al. reported that the levels of serum IGFBP-1 were
similar in short children born SGA and AGA [35].
Kistner A et al. investigated the serum markers ofinsulin resistance in adults born SGA and reported that
lower IGFBP-1 and triglyceride levels were observed in
the SGA group compared to the AGA group despite
with normal BMI [36]. In our study, there were no
marked differences in IGFBP-1 and triglyceride levels
between SGA children with height and BMI catch-
up growth and their age-matched controls. In SGA
children, especially non-catch-up growth subjects, the
lower BMI may have influenced IGFBP-1and triglyceride
levels, although we had adjusted for BMI. Further ana-
lysis showed that IGFBP-1 correlated significantly with
the HOMA-IR. values. These differences and correla-
tions were not observed with triglyceride levels. In this
instance, our results were similar to the results published
by Evagelidou EN et al., who reported that SGA
children, although more insulin-resistant, had similar tri-
glyceride levels to AGA children in pre-puberty [37].
Our findings indicated that adiponectin might be a more
effective marker than IGFBP-1 and triglyceride for moni-
toring insulin resistance in SGA children with catch-up
growth. However, these three markers were not sensitive
enough at this age stage in non-obese SGA children.
We need to be aware of the limitations in interpreting
the results of this study. The major limitation of the
present study is the relatively small sample size. Another
limitation is that the study design was based on retro-
spective data collecting. The third limitation is that both
body fat and insulin resistance were studied using surro-
gate variables. These limitations might suggest that the
results are not easily applicable to the whole population
of pre-pubertal SGA children. However, we have pre-
sented the presence of four different SGA populations
compared to normal controls in the exploration of
system-wide adiponectin, IGFBP-1, triglyceride levels
and insulin resistance in SGA children, while consider-
ing height and fat catch-up growth.
In conclusion, our study showed that children born
SGA with catch-up growth for height and BMI are more
insulin-resistant than children born AGA. Our study indi-
cated that interventions to control overweight develop-
ment in childhood seem to be important for preventing
insulin resistance. Furthermore, lower levels of adiponec-
tin were closely correlated with height and BMI catch-up
growth in SGA children. Adiponectin may be a more use-
ful marker than IGFBP-1 and triglyceride for monitoring
insulin resistance in SGA children with catch-up growth.
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